Background: Limited data are available as to the relationship between computed tomography (CT) derived data on emphysema and airway wall thickness, and quality of life in subjects with chronic obstructive pulmonary disease (COPD). Such data may work to clarify the clinical correlate of the CT findings. Methods: We included 1778 COPD subjects aged 40e75 years with a smoking history of at least 10 pack-years. They were examined with St George's Respiratory Questionnaire (SGRQ-C) and high-resolution chest CT. Level of emphysema was assessed as percent lowattenuation areas less than À950 Hounsfield units (%LAA). Airway wall thickness was estimated by calculating the square root of wall area of an imaginary airway with an internal perimeter of 10 mm (Pi10). Results: In both men and women, the mean total score and most of the subscores of SGRQ-C increased with increasing level of emphysema and increasing level of airway wall thickness, after adjusting for age, smoking status, pack years, body mass index and FEV 1 . The highest gradient was seen in the relationship between the activity score and the emphysema level. The activity score increased by 35% from the lowest to the highest emphysema tertile. The relationship between level of emphysema and the total SGRQ-C score became weaker with increasing GOLD (Global initiative for Chronic Obstructive Lung Disease) stages (p < 0.001), while the impact of gender was limited. Conclusion: In subjects with COPD, increasing levels of emphysema and airway wall thickness are independently related to impaired quality of life. ª
Introduction
Chronic Obstructive Pulmonary Disease (COPD) is among the leading causes of death worldwide and associated with a substantial morbidity. 1 COPD is characterized by airflow limitation, which forms the basis for the diagnosis and staging of the disease. 2 However, it is widely acknowledged that airflow limitation in terms of forced expiratory volume in 1 s (FEV 1 ) and forced vital capacity (FVC) does not explain the whole picture of COPD. 3 The functional abnormalities are known to be caused by changes to the lung anatomy, and it is thought that small airway remodeling and emphysematous destruction contribute independently to the functional abnormalities. Computed tomography (CT) of the chest offers the opportunity to divide the disease into anatomically based phenotypes of disease, commonly referred to as emphysematous or airway phenotypes. 4 It is thought that a more complete anatomic description of the lung will allow for the possibility to study more specific COPD related genes and biomarkers than when using spirometry alone. 5, 6 From a patient perspective the concept of airway wall thickening and level of emphysema as measured by CT remains abstract. A major concern to the patient is the level of respiratory symptoms, particularly dyspnea, as well as quality of life (QoL). While the relationship of respiratory symptoms to CT findings has recently been examined, 7, 8 limited data are available as to how CT derived emphysema level and airway wall thickness relate to QoL. In a selective group of advanced COPD patients examined prior to lung volume reduction surgery, lung transplantation or resection for potential bronchogenic malignancy, Han et al. found increased level of emphysema and airway wall thickness related to impaired quality of life. 9 In two other studies comprising primarily men, increased level of emphysema was also found to be associated to a worse quality of life. 10, 11 A recent report from the COPDGene trial found both level of emphysema and airway wall thickness related to impaired QoL in terms of St George Respiratory Questionnaire (SGRQ), with airway wall thickening being more strongly related to QoL than extent of emphysema. 12 To our knowledge, no data are available as to whether the relationship between CT derived emphysema and airway thickness and QoL differ by gender or whether the CT-QoL relationships vary with severity of disease. Such data may work to clarify the clinical correlate of the CT findings and enhance the interpretation of chest CT in the clinical setting.
We hypothesized that emphysema and airway wall thickness are independently associated to impaired level of QoL. To test this hypothesis, we used the "Evaluation Of COPD Longitudinally To Identify Predictive Surrogate Endpoints (ECLIPSE) Study (Clinicaltrials.gov identifier NCT00292552; GSK Study Code SCO104960). ECLIPSE includes questionnaires, spirometry, exercise testing and computed tomography (CT) scans from smokers suffering from COPD, non-smoker controls and smoker controls with no evidence of COPD which offers the opportunity to examine to what extent CT findings explain QoL status beyond that offered by spirometry. Finally, we aimed to examine to what degree the CT-QoL relationship varies by gender and disease status.
Methods Participants
The population under study was the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) cohort. The trial has been approved by the relevant ethics and review boards at participating centers and written informed consent was obtained from all participants. A list of all participating centres can be found in Appendix 2. The aims and operational aspects of the ECLIPSE cohort have been described elsewhere. 13 Individuals aged 40e75 years were recruited to the study if they had a smoking history of !10 pack-years, a postbronchodilator ratio between forced expiratory volume in 1 s (FEV 1 ) and forced vital capacity (FVC) 0.7. In the current analysis only COPD subjects were included, because the SGRQ-c was developed to assess quality of life in COPD subjects. Individuals recruited to the study were genotyped for a 1 -antitrypsin deficiency and six PiZZ and 11 PiSZ individuals were identified and also excluded from the analysis. 5 
Pulmonary function testing
Pulmonary function testing (PFT) included postbronchodilator forced expiratory volume in one second as percentage of predicted (FEV 1 %) and forced vital capacity (FVC) with a pneumotachograph, performed following American Thoracic Society (ATS) guidelines. Subjects were asked to withhold bronchodilator medication for at least 6 h prior to testing. COPD subjects were staged according to the GOLD guidelines. 14 
Computed tomography
Computed tomography scans were acquired using multidetector-row CT scanners (GE Healthcare or Siemens Healthcare) with a minimum of 4 rows and obtained in supine position, at suspended full inspiration without administration of intravenous contrast. Exposure settings were 120 kVp and 40 mAs and images were reconstructed at 1.0 mm (Siemens) or 1.25 mm (GE) contiguous slices, using a low spatial frequency reconstruction algorithm (GE: Standard, Siemens: b35f). CT scanners were calibrated regularly and a standard CT phantom was scanned by all participating centers to produce comparable data.
All CT scans were analyzed using Pulmonary Workstation 2.0 software (VIDA Diagnostics, Iowa City, IA). Briefly, the lungs were segmented from the thorax wall, heart and main pulmonary vessels, followed by segmentation of the individual lobes. The airways were segmented using a region growing algorithm starting in the trachea and projecting to the smallest airway visible on the CT scan as previously described. 15, 16 For this study, only third ("segmental" based on the Boyden classification 17 to fifth generation airways were analyzed, since the number of segmented airways dropped massively beyond the fifth generation.
We standardized airway wall area using the subject specific regression equation between the square root of Aaw of all included airways of that subject and their Pi to calculate the square root of the wall area for an imaginary airway with an internal perimeter of 10 mm (Pi10). 18 By applying this standardization, we adjusted for differences in number of segmented airways and differences in locations of the segmented airways within the bronchial tree.
The extent of emphysema (% low attenuation areas, % LAA) was estimated using the threshold technique quantifying the percent of lung voxels with an apparent X-ray attenuation value below À950HU.
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Quality of life
We used the St George's Respiratory Questionnaire (SGRQ-C) to determine the impact of COPD on quality of life. 20 This is a supervised self-administered questionnaire designed specifically for use in respiratory disease and contains three domains: symptoms (relating to cough, phlegm, wheezing and dyspnea); activity (relating to physical activity limited by dyspnea); and impact (relating to control, panic, medication and expectations). A total score was calculated from all three domains. A subscore was estimated for each domain.
Statistics
Proportions were tested via chi-squared tests; means were compared by ANOVA and medians were compared by KruskaleWallis tests. Normalized values were calculated as (value-mean)/standard deviation (SD) in order to standardize 1 unit to 1 SD.
The associations between each of %LAA and Pi10 and the components of the SGRQ-C questionnaire were examined by multiple linear regression models with each of the SGRQ total score and sub-scores as dependent variables. The predictors of interest in the models were %LAA and Pi10 adjusted for age, smoking status, pack years, body mass index (BMI), and FEV 1 . Analyses were stratified by sex and by GOLD stage.
In order to compare the %LAA correlation coefficient to that of Pi10, the linear regression analyses were performed including both %LAA and Pi10 as predictors simultaneously. %LAA and Pi10 were then also used as normalised parameters, implying that one unit change corresponds to 1 SD change for that variable. Individual respiratory symptoms (the cough, phlegm and wheezing questions of the SGRQ-C) and the relationship of Pi10 to each of the respiratory symptoms were examined by multiple logistic regression models with each symptom as dependent variable and Pi10 as the independent variable adjusted for age, smoking status, pack years, body mass index (BMI), and FEV 1 .
P-values less than 0.05 were considered significant. All analyses were performed with SAS Ò Version 9.1 (SAS Institute Inc., Cary, NC, USA).
Results
In total 2161 COPD patients GOLD stage IIeIV were enrolled in ECLIPSE; an additional 3 subjects were identified as GOLD stage I. Of these participants, 386 (18%) were excluded from the current analysis due to lack of suitable CT scan or inability to calculate Pi10. Characteristics of the study sample (n Z 1778 COPD cases) are shown in Table 1 . Women were slightly older, had less airflow limitation and a lower BMI than men. In this population of COPD subjects, there was a significant association between %LAA and FEV 1 % predicted (r Z À0.49; p < 0.001), FEV 1 % was weakly correlated to Pi10 (r Z À0.11; p < 0.001).
CT derived parameters vs quality of life
Men and women were divided into tertiles by the extent of emphysema and by airway wall thickness. Table 2 shows the SGRQ-C total scores and subscores for each tertile. The mean total score and almost all subscores of St George's Respiratory Questionnaire increased with greater extent of emphysema in both men and women and with increase in airway wall thickness in men. The greatest increase was seen for the activity score, increasing by about 35% from the lowest to the highest emphysema tertile for both men and women. In women, increasing airway wall thickness did not result in an increase in SGRQ-C scores.
In the multiple linear regression analyses using nonnormalized data, the total SGRQ-C and also the subscores were significantly correlated to the extent of emphysema. This was observed in both men and women (Table 3A) . Results were adjusted for age, smoking status, pack years and body mass index (BMI). Similar trends were noted for the relationship between airway wall thickness levels and the quality of life scores (Table 3A) . The exception was the relationship between activity score and Pi10 in women, which did not vary significantly. FEV 1 percent predicted was then added to the regression analyses. The coefficients for the relationships between emphysema and quality of life scores were reduced, but remained significant for the activity and the total scores in men and for the total score in women. The coefficients between airway wall thickness and the SGRQ-C scores remained significant for the impact, symptoms and total scores in both men and women (Table 3A) .
We also performed multiple regression analysis stratified by GOLD stage for the total SGRQ-C score and its domain scores. %LAA was significantly associated with the total score and the activity score in GOLD stages II and III, but not in GOLD stage IV (Table E1) . Additionally, %LAA was associated with the symptoms score domain in GOLD stage II. Pi10 was significantly associated with the total score and the impact score in GOLD stages III and IV, but not in GOLD II. There were no significant relationships observed between the impact score and %LAA or activity score and Pi10 in any GOLD stage.
Additional logistic regression analyses showed that Pi10 was associated with all the respiratory symptoms indicative of airway disease manifestation (cough, phlegm, wheezing), after adjusting for gender, age, smoking status, pack years, BMI and FEV 1 percent predicted (Table 4) .
Finally, level of emphysema and airway wall thickness were added simultaneously to the linear regression equation in addition to gender, age, smoking status, pack years, body mass index and FEV 1 percent predicted (Table 3 ). Pi10 remained significantly related to all the SGRQ-C scores except the activity score, while %LAA was still significantly associated with the activity and total scores. The relationship between SGRQ-C total scores and extent of emphysema was similar to the relationship between SGRQ-c total scores and airway wall thickening. Activity scores were only significantly related to %LAA and not to Pi10, while impact score and symptoms scores were only significantly related to Pi10.
In order to be able to compare the %LAA correlation coefficient to those of Pi10, the analyses were repeated with normalised parameters (Table 3 ). This analysis shows that correlation coefficients for total scores are comparable for %LAA and Pi10. Extent of emphysema is more strongly associated to activity score, while impact score and symptoms score are more strongly related to airway wall thickening. 
Discussion
In this large population of COPD cases, we have shown that both the extent of emphysema and airway wall thickness are significantly related to impaired quality of life measured using the SRGQ-C total scores. Airway wall thickness was also independently related to the impact and symptoms scores while emphysema was significantly associated to the activity score. This study confirms previous observations in selected COPD subjects that emphysema and airway wall thickness are related to quality of life.
9e12 Furthermore, the current study expands previous results by showing that these relationships are present in both men and women. For emphysema the relationship decreases with increasing severity of COPD, while the correlation between Pi10 and SGRQ-C became stronger with increasing GOLD stage.
The relationship between emphysema and the activity score was clearly stronger than the relationship between emphysema and the symptoms score (Table 3 ). This is in line with recent findings from the COPDGene cohort. 12 The reported effect can be due to the fact that COPD patients reduce their activity as the disease progresses and thereby experience relatively reduced level of dyspnea. 21 Hence, asking the patients about level of dyspnea may not capture the disease severity to the same extent as asking them about activity level. If this is true, our findings indicate that the recently reported relationship between CT derived level of emphysema and dyspnea might be underestimated. 7 Airway wall thickening was more strongly related to impact and symptoms scores, while emphysema was not. This is not surprising since cough and phlegm symptoms were reported to be related to airway wall thickness, but not to emphysema. 7 We also reported significant associations between Pi10 and respiratory symptoms.
The relationship between the CT derived extent of emphysema and airway wall thickness and activity scores may be partly explained by dyspnea on exertion. However, the impaired activity in COPD could also be due to muscle atrophy, osteoporosis, cardiac co-morbidities and general fatigue all of which may be related to emphysema. 22, 23 The CT indices of both emphysema and airway remodelling were related to the impact score, but after adjusting for FEV 1 percent predicted, only the association between airway wall thickness and the impact score remained significant (Table 3 ). This may indicate that the psychosocial impact of COPD is at least partly reflected by the extent of airflow limitation which is more strongly related to emphysema than to airway wall thickness. 24 The relationships between the extent of emphysema and the total score and all the subscores of SGRQ-C became weaker with increasing GOLD stage. This indicates that aspects other than emphysema become more important to QoL as the disease progresses, also reflected by the correlation coefficients for the association between Pi10 and total scores that increased with increasing GOLD stage.
The decline in the relationship between emphysema and QoL relationship with increasing disease severity may partly be explained methodologically as SGRQ-C was developed in COPD subjects not housebound. 20 Hence, the SGRQ-C may reflect QoL more poorly in patients with end stage disease as compared to less severe stages. Men and women did not differ in their SGRQ-C total scores despite the fact that men had a slightly worse FEV1% predicted, but we reported that activity scores for women are greater than for men, while symptoms scores were greater for men. It is worth noticing that although the level of emphysema was greater in men than women with similar SGRQ-C scores, the emphysema-QoL relationships did not differ by gender. This implies that the relative contribution of emphysema to the QoL differs in men and women.
For the current study CT emphysema was defined as areas with an attenuation below À950 HU. Although Madani et al. have suggested that for multislice imaging the correlation between extent of low attenuation areas and extent of emphysema at histology is strongest for a threshold of À960 HU, 25 the threshold of À950 HU is still widely used, including the study by Martinez et al. 12 By using the À950 HU threshold, our results are easier to compare the results from other studies. This paper has several strengths. It is based on a large COPD cohort, allowing for subgroup analyses that have not been possible in previous studies on this topic. Furthermore, the subjects were recruited from 46 centres covering populations in Europe and North America and although the sample is not a true population sample, the study cohort includes subjects that comprise the majority of clinical relevant cases in the COPD population at large (GOLD stage 2 and 3). 25 Finally, QoL was assessed by SGRQ-C which has been extensively validated in COPD subjects. 26 Some limitations should also be acknowledged. The measurement of airways was performed by segmenting the airway tree as far as possible on the CT scans. As a result, only airways that can be segmented by the software are measured and these are mainly large airways. It is possible that airways that are severely affected by inflammation and show serious lumen narrowing cannot be segmented and therefore cannot be analyzed. However, Nakano et al. have shown that wall thickness of the large airways is a good surrogate for wall thickness of small airways 18 and numerous studies have shown that measurements of these medium sized airways correlate with lung function. 27 Studies have also shown that the number of airways seen on CT is lower in subjects with COPD than in smoker controls. 28 Moreover, McDonough has shown that the drop in airway number seen using CT is reflective of the drop in the small airway number count using detailed micro-CT 29 and that the airways that are remaining are thicker than in control subjects. 29, 30 Another surrogate for small airways disease is thought to be the presence of air trapping on expiratory CTs. 31 Unfortunately, while this would provide useful data, expiratory CTs were not performed in ECLIPSE and we are unable to comment on air trapping. Therefore, while it is likely that we underestimated the severity of airway disease in COPD subjects by the inability to segment the small and severely affected airways we believe that our findings are indicative of the anatomic changes to airway size and number in COPD.
The CT scans were not spirometrically gated. However, it has been shown that the repeatability of quantitative CT tests is high and not likely to improve by using spirometric gating. 32 We also performed the analyses with CT parameters corrected for inflation level using the ratio of the CT derived lung volume to the lung volume measured by plethysmography. Adding this ratio to the equations made only small, non significant changes to the reported coefficients (data not shown).
Another limitation is that the extent of emphysema is represented as the percentage of the lung showing low Xray attenuation. However, level of inspiration during the scan, cardiac congestion, fibrosis and increased phlegm production will reduce %LAA, while image noise can increase the level of %LAA thereby influencing the specificity of %LAA as an indicator of emphysema. Finally, this analysis is cross-sectional in design and conclusions about how changes in anatomy affect changes in the SGRQ-C scores cannot be assessed from this study.
Conclusion
COPD is a complex disease with symptoms that extend beyond simple airflow limitation, as measured by FEV1, into other spectrums including their quality of life. The data from the current study show that both lung parenchyma and airway wall measurements obtained using quantitative CT scans provides information on the anatomic changes that are causing the functional and quality of life changes seen in COPD. These techniques may be useful to sub-divide patients into specific groups for testing of hypothesis related to pathogenesis of disease and for testing novel therapeutics.
